Ladophar Pharmaceutical Research & Application Co., Ltd announced that it will receive VND 40,000,000,000 in its equity round of funding on April 12, 2022. The transaction includes participation from existing investor Lamdong Pharmaceutical Joint Stock Company. Post-closing of the transaction, the investor will retain its 100% stake in the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
21,900 VND | +0.46% | -1.35% | +37.74% |
1st Jan change | Capi. | |
---|---|---|
+37.74% | 10.93M | |
+51.63% | 796B | |
+41.51% | 628B | |
-5.10% | 358B | |
+19.90% | 331B | |
+9.95% | 301B | |
+17.66% | 244B | |
+3.39% | 228B | |
+10.75% | 214B | |
+6.99% | 165B |
- Stock Market
- Equities
- LDP Stock
- News Lamdong Pharmaceutical
- Ladophar Pharmaceutical Research & Application Co., Ltd announced that it expects to receive VND 40 billion in funding from Lamdong Pharmaceutical Joint Stock Company